Mucosal healing is an important therapeutic end point in clinical trials and clinical practice. There is no validated definition of mucosal healing in patients with inflammatory bowel disease, although the…
It has been proposed that effective disease control through abrogation of inflammation in IBD may also reduce CRC risk in these individual patients. This article summarizes the potential for medical…
Interval colorectal cancers (CRCs) may account for approximately one half of all CRCs identified during IBD surveillance. The etiology of interval CRCs is multifactorial, with procedural factors likely to play…
This article advocates the use of chromoendoscopy to detect flat lesions over the use of colonoscopy alone. The authors illustrate their point by telling the story of their father, who…
Patients with inflammatory bowel disease colitis have an increased risk of developing colorectal cancer compared with the general population. Colonoscopic surveillance remains challenging because the cancer precursor (dysplasia) can have…
Charles J. Lightdale, MD, Consulting Editor It has become increasingly evident that American gastroenterologists have become overly dependent on random biopsies whether in the esophagus, stomach, or colon. Times have…
